No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection

Postmarketing cases of hepatitis B virus (HBV) reactivation during hepatitis C treatment have been reported. We analyzed serum samples from patients in a clinical trial of ledipasvir-sofosbuvir in Taiwan and Korea. Of the 173 patients enrolled, 103 (60%) had been previously infected with HBV. None s...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Infect Dis
Main Authors: Sulkowski, Mark S., Chuang, Wan-Long, Kao, Jia-Horng, Yang, Jenny C., Gao, Bing, Brainard, Diana M., Han, Kwang-Hyub, Gane, Edward
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Brief Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6276897/
https://ncbi.nlm.nih.gov/pubmed/27486112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw507
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki